SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: StockMiser who wrote (2229)2/9/2000 12:27:00 PM
From: Hank   of 5582
 
SM,,

Thanks for a lucid and well educated assessment of GUMM and it's lead product Zicam. It's nice to finally meet somebody on this thread that actually understands the science and rationale behind my arguments. I agree 100% with everything you said except one thing. You said:

"So this is my final risk factor - Gumtech management for goofing the science and blowing a huge opportunity."

While the AJIC withdrawal could certainly have been a screw up on GUMM's part, it could also have been intentional in order to get free media attention. After all, if you have a product that is based on questionable science and you know it, what better way to make it seem legitimate than to have it submitted for publication and then intentionally "screw up" so that the data never sees the light of day (and consequently avoid close scrutiny). I'm not saying they did this but it is a viable possibility in my book.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News